YN
Yigal Nochomovitz Citigroup Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
67
Avg Return
Past Year
Past Year
16%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
82.4%
Neutral
16.2%
Negative
1.5%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Downgraded
| $97 | – | 1 | +54% |
–
| 29 Sep ‘25 5 months ago |
|
|
|
Buy
Maintained
| $69 |
258%
upside
| 1 | -45% |
0
%
| 11 Aug ‘25 6 months ago |
|
|
|
Buy
Maintained
| $22 |
11%
downside
| 2 | +53% |
0
%
| 11 Aug ‘25 6 months ago |
|
|
|
Buy
Maintained
| $1.90 |
16%
upside
| 1 | +43% |
0
%
| 7 Aug ‘25 7 months ago |
|
|
|
Buy
Maintained
| $52 |
331%
upside
| 3 | -14% |
0
%
| 1 Aug ‘25 7 months ago |
|
|
|
Sell
Initiated
| $7 |
57%
downside
| 1 | -22% |
0
%
| 24 Jul ‘25 7 months ago |
|
|
|
Buy
Maintained
| $9 |
283%
upside
| 1 | -37% |
0
%
| 9 Jul ‘25 7 months ago |
|
|
|
Buy
Maintained
| $55 |
86%
upside
| 1 | +45% |
0
%
| 6 Mar ‘25 1 year ago |
|